Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: a further step toward new evidence
- PMID: 29607124
- PMCID: PMC5864636
- DOI: 10.21037/jtd.2018.01.19
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: a further step toward new evidence
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.JAMA Oncol. 2018 Jan 11;4(1):e173501. doi: 10.1001/jamaoncol.2017.3501. Epub 2018 Jan 11. JAMA Oncol. 2018. PMID: 28973074 Free PMC article. Clinical Trial.
References
-
- Eberhardt WE, Mitchell A, Crowley J, et al. The IASLC lung cancer staging project: proposal for the revisions of the M descriptors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2015;10:1515-22. - PubMed
-
- Agolli L, Valeriani M, Nicosia L, et al. Stereotactic ablative body radiotherapy (SABR) in pulmonary oligometastatic/oligorecurrent non-small cell lung cancer patients: a new therapeutic approach. Anticancer Res 2015;35:6239-45. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources